Mangoceuticals, Inc. Common Stock

Mangoceuticals, Inc. Common Stock

MGRX · NASDAQ · Healthcare / Health Information Services

0.155USD-0.03 (-16.22%)

Price History

Full chart

Market Stats

Previous Close0.185
Open0.1721
Day Range0.1495 – 0.1876
52-Week Range0.162 – 2.75
Volume962.07K
Market Cap8.30M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.00
Dividend Yield0.00%
Beta2.05
50-Day Avg0.4553
200-Day Avg0.4734

About

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. In addition, the company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Jacob D. Cohen
  • Employees3
  • Headquarters17130 N. Dallas Parkway, Dallas, TX, United States, 75248, USA
  • Websitehttps://www.mangoceuticals.com

Leadership

  • Mr. Jacob D. CohenCo-Founder, CEO & Chairman · b. 1979
  • Mr. Eugene M. JohnstonChief Financial Officer · b. 1964

Financials

Income Statement

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-8.94K731.49K615.87K456.02K
Growth (%)--+8083.16%-15.81%-25.96%
Cost of Revenue-4.09K299.99K235.91K205.63K
Gross Profit-4.85K431.50K379.96K250.39K
Gross Margin-54.26%58.99%61.70%54.91%
Operating Expense-2.00M9.65M8.35M19.41M
Operating Income-17.52K-1.99M-9.22M-7.97M-19.15M
Operating Margin--22279.70%-1260.28%-1294.42%-4200.46%
EBITDA-17.52K-1.99M-8.09M-7.96M-18.82M
EBITDA Margin--22236.48%-1106.44%-1292.80%-4126.07%
Net Income-17.70K-2.00M-9.21M-8.71M-20.64M
Net Income Margin--22352.11%-1259.40%-1413.60%-4526.86%
Interest Expense1816.47K013.70K103.51K
Interest Expense % of Total Revenue-72.41%0.00%2.22%22.70%

Balance Sheet

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets22.55K1.00M1.05M15.37M16.09M
Total Liabilities39.27K389.26K276.04K1.43M890.57K
Total Equity-16.72K614.03K774.75K13.95M15.20M
Cash22.55K682.86K739.01K58.65K1.49M
Total Debt39.27K352.87K128.68K214.96K307.82K
Net Debt16.72K-330.00K-610.33K156.31K-1.18M

Cash Flow

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-17.52K-1.35M-7.00M-4.86M-5.85M
Investing Cash Flow-43.10K-43.10K-3.52K65.00K-
Financing Cash Flow40.07K2.05M7.06M4.13M7.27M
Capital Expenditure43.10K43.10K3.52K05
Free Cash Flow-17.52K-1.39M-7.00M-4.86M-5.85M
Dividends Paid---802.11K-
FCF to OCF100.00%103.20%100.05%100.00%100.00%
Dividend Paid to FCF----16.49%-

Earnings

Report DateSep 26, 2022Feb 6, 2023May 10, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Mar 20, 2025May 15, 2025Aug 14, 2025Nov 14, 2025Dec 31, 2025Mar 31, 2026Aug 13, 2026Nov 13, 2026
EPS Estimate0.000.00---------------
EPS Actual-0.02-0.06-0.23-2.05-1.70-1.80-1.56-1.37-0.99-1.08-1.29-0.54-0.69-0.19-0.22-0.09-
Surprise-----------------
Timing-----------------

Key Statistics & Ratios

Market Cap8.30M
Enterprise Value9.89M
Trailing P/E0.00
Forward P/E0.00
Price / Sales26.33
Price / Book0.78
EPS-1.00
Book Value0.695
Revenue (TTM)315.23K
Gross Profit (TTM)171.59K
EBITDA-12.10M
Profit Margin0.00%
Operating Margin-1502.45%
Return on Equity-95.10%
Return on Assets-46.97%
Shares Outstanding21.57M
Shares Float17.83M
Beta2.05
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
5.62%
Insiders
7.99%
Retail / Other
86.39%

Top Institutional Holders

  • Citadel Advisors Llc
    338.96K1.57%
  • Geode Capital Management, LLC
    194.48K0.90%
  • Ikarian Capital, LLC
    138.15K0.64%
  • Vanguard Capital Management, LLC
    123.04K0.57%
  • Jane Street Group LLC
    72.75K0.34%
  • Virtu Financial LLC
    61.03K0.28%
  • Vanguard Fiduciary Trust Co
    57.16K0.27%
  • BOOTHBAY FUND MANAGEMENT, LLC
    38.44K0.18%
  • Northern Trust Corp
    37.58K0.17%
  • Ackerman Capital Advisors, LLC
    34.50K0.16%
  • ACT Advisors, LLC
    26.86K0.12%
  • StoneX Group Inc
    16.04K0.07%
  • XTX Topco Ltd
    13.14K0.06%
  • Sunbelt Securities
    12.00K0.06%
  • The Goldman Sachs Group Inc
    11.76K0.05%
  • Csenge Advisory Group, LLC
    10.00K0.05%

Top Fund Holders

  • Fidelity Extended Market Index
    76.53K0.35%
  • Fidelity Nasdaq Composite Index
    44.40K0.21%
  • Fidelity Series Total Market Index
    14.44K0.07%
  • Fidelity Total Market Index
    12.61K0.06%

Stock Splits

  • Oct 16, 20241:15